key: cord-0862587-xg2cbx75
authors: Wang, Cheng; Wang, Shaobo; Li, Daixi; Wei, Dong-Qing; Zhao, Jinghong; Wang, Junping
title: Human Intestinal Defensin 5 Inhibits SARS-CoV-2 Invasion by Cloaking ACE2
date: 2020-05-11
journal: Gastroenterology
DOI: 10.1053/j.gastro.2020.05.015
sha: f743b029f309a58218d5f1cff1ad45fd4e579065
doc_id: 862587
cord_uid: xg2cbx75

nan

Angiotensin-converting enzyme-2 (ACE2) is the main receptor of SARS-CoV-2 S1 and mediates viral entry into host cells 1 . In human, ACE2 is remarkably abundant on the membrane of lung alveolar epithelial cells and enterocytes 2 . Human intestinal epithelium encompasses approximately 200 m 2 of surface area and is conceivably susceptible to SARS-CoV-2. However, the occurrence of intestinal symptoms is lower than that of respiratory symptoms as a whole 3 , indicating that enterocytes are actually not so easy to be infected by SARS-CoV-2 as expected. The underlying reason is desirable to be explored.

Intermolecular interaction was determined by biolayer interferometry (BLI). Molecular dynamic simulation (MDS) was performed on ZDOCK server. SARS-CoV-2 S1 binding and S pseudovirions entry to targeted cells were investigated by immunofluorescence microscopy, Western blot, and luciferase assay. The significant differences (P) were calculated by SPSS 25.0. More details are shown in Supplementary Methods.

Interaction between human defensin-5 (HD5) and ACE2 HD5, the most abundant α defensin specifically secreted by intestinal Paneth cells, is in contact with ACE2 on the membrane of enterocytes (Supplementary Figure 1A) . The affinity of HD5 binding to ACE2 was 76.2 nM ( Figure 1A ), whereas no association signal was observed for HD5 RED and another intestinal α defensin HD6 (Supplementary Figure 1B, C) .

In ileal fluid, the content of HD5 is quantified to 6-30 µg/mL (1.67-8.37 µM). Such a high content of HD5 allows an interaction with ACE2 before SARS-CoV-2 lands to enterocytes, although the affinity of SARS-CoV-2 S1 binding to ACE2 is higher than that of HD5 binding to ACE2 ( Figure 1B) . Actually, BLI-based blocking assay revealed that HD5 preincubation weakened the binding of SARS-CoV-2 S1 to ACE2 ( Figure 1C ).

We then investigated the ACE2 blocking by HD5 using MDS, in which HD5 was docked onto the ligand-binding domain (LBD) of ACE2. After 20 ns of simulation, the complex conformation kept stable with minor residue fluctuations (Supplementary Figure 1D ). The free binding energy of HD5 interacting with LBD was -1866.53 KJ/mol, which was much higher than that of HD5 docking onto SARS-CoV-2 RBD (163.24 KJ/mol, Supplementary Figure 1E ). Driven by the potent intermolecular interaction, HD5 attached LBD and cloaked Thr 7 , Gln 24 , Asp 30 , and Lys 31 on α-helix 1 and Tyr 83 on loop 2 ( Figure 1D ).

Confocal microscopy observed that SARS-CoV-2 S1 largely adhered to the surface of human intestinal epithelium Caco-2 cells in the absence of HD5 after 1 h of co-incubation ( Figure   1E ). When cells were preincubated with 100 µg/mL of HD5 for 15 min, the recruitment of SARS-CoV-2 S1 was dramatically reduced. Western blot supported that HD5 protected cells from the adherence of SARS-CoV-2 S1 in a dose-dependent manner ( Figure 1F) . Notably, SARS-CoV-2 S1 pretreated with HD5 was still efficient to contact Caco-2 ( Supplementary   Figure 2A) . Furthermore, SARS-CoV-2 S pseudovirions containing pLenti-GFP and dual-luciferase reporter system 4 were employed to determine the influence of HD5 on viral entry. Cells infected by the pseudovirions produced GFP and the fluorescence signal in the cytoplasm was visibly reduced in the cells pretreated with HD5 (Supplementary Figure 2B) .

Luciferase assay confirmed that HD5 significantly inhibited SARS-CoV-2 S pseudovirions entry to cells at concentrations as low as 10 µg/mL ( Figure 1F ).

Intestinal epithelium encounters trillions of microorganisms including various viruses. To cope with the microbial threat, intestinal cells have evolved to produce antimicrobial peptides including HD5, which is a lectin-like peptide able to bind lipids and glycosylated proteins 5 . In this study, we found a structure-dependent interaction between HD5 and ACE2. The binding of HD5 to ACE2 cloaked several sites in LBD, among which Asp 30 and Lys 31 are crucial for SARS-CoV spike to bind ACE2 6 . Accordingly, SARS-CoV-2 S1 binding and S pseudovirions entry to enterocytes were inhibited by HD5 (Supplementary Figure 2C) . To our knowledge this is the first study demonstrating the innate defense function of human intestine against SARS-CoV-2.

Our finding is a reasonable explanation to the clinical phenomenon that few intestinal symptoms are observed in COVID-19 patients 3 . Due to the deficiency in HD5, patients receiving small intestine transplantation or suffering from inflammatory bowel diseases such as the Crohn's disease, might be more susceptible to SARS-CoV-2 than the healthy 7 . HD5 also inhibited SARS-CoV-2 S pseudovirions entry to human renal proximal tubular epithelial cells (Supplementary Figure 2D) , demonstrating an extensive protection of HD5. For the shortage of effective drugs to prevent and treat COVID-19, we think that it may be a useful strategy to increase the content of HD5 in vivo by oral administration as we recently described 8 . Immunofluorescence microscopy revealing the protection of HD5 on Caco-2 exposed to SARS-CoV-2 S1. SARS-CoV-2 S1 adhering to the cell surface is probed by a goat anti-rabbit Alexa Fluor 488 antibody (Green). Nuclei are stained using DAPI (blue). The embedding graph in sham group shows cells treated with HD5. The region of interest in SARS-CoV-2 S1-treated group is magnified in the embedding graph. (F) Luciferase assay. The experiment was conducted in triplicate and repeated three times in different days. Results are shown as mean ± standard deviation. Welch test indicated the differences among the groups excluding the sham group (F = 52.15, P = 1.51 × 10 -9 ). LSD test showed that, compared with the control group without HD5 treatment (n = 9; 148.2 (27.5%)), Caco-2 cells preincubated with HD5 for 1 h at concentrations of 10 µg/mL (n = 9; 68.88 (28.95 %); ****, P = 3.23 × 10 -10 ), 50 µg/mL (n = 9; 2.25 (47.07 %); ****, P = 2.89 × 10 -18 ), and 100 µg/mL (n = 9; 1.59 (37.69 %); ****, P = 2.48 × 10 -18 ) were less sensitive to SARS-CoV-2 S pseudovirons invasion. The embedding graph shows the protein bands of SARS-CoV-2 S1 binding to Caco-2 treated with HD5. β-actin is the reference.

Author names in bold designate shared co-first authorship